Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02532361 · ClinicalTrials.gov registry record
Proportion of Hysterectomy After Female Sterilization
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 10,578
- Enrollment target
NCT02532361: Completed study, sponsored by Bayer.
NCT02532361 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 10,578 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02532361 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 10,578 participants
- Enrollment target
Study Summary
The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.
Primary Outcome
The study will also describe sub-outcomes related to post-sterilization hysterectomy procedure including: i. Average time (in days) from index date (sterilization) to hysterectomy ii. Percentage of patients having hysterectomy (abdominal) iii. Percentage of patients having hysterectomy (vaginal) iv. Percentage of patients having hysterectomy (laproscopically assisted vaginal hysterectomy - LAVH) v. Percentage of patients having hysterectomy (abdominal, vaginal and LAVH)
Interventions
- PROCEDURE Tubal ligation
- DEVICE Hysteroscopic device placement including Essure (ESS305, BAY1454032)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,578 participants |
| Start Date | 2015-08 |
| Est. Completion | 2015-12 |
What the finished NCT02532361 record still lists
NCT02532361 is an observational study that tracks outcomes without assigning an intervention. Its 10,578 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Tubal ligation is the first listed.
NCT02532361 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02532361 about?
NCT02532361 is a clinical study titled "Proportion of Hysterectomy After Female Sterilization". The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.
What is the current status of trial NCT02532361?
This trial is currently completed. The enrollment target is 10,578 participants. The study started on 2015-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02532361?
The interventions under investigation include: Tubal ligation (PROCEDURE), Hysteroscopic device placement including Essure (ESS305, BAY1454032) (DEVICE).
Who is sponsoring clinical trial NCT02532361?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
- NCT06891222 · 10,500 participants
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
- NCT07157774 · 10,450 participants · Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia